Biogened (WAR:BGD) E10: zł1.37 (As of Mar. 2026)


WAR:BGD Biogened SA WAR:BGD
68 GF Score
Price zł18.40
GF Value zł23.81
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Biogened E10?

Biogened WAR:BGD 68 E10 is zł1.37 as of Mar. 2026. GuruFocus rates WAR:BGD with a GF Score™ of 68/100 and a GF Value™ of zł23.81 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biogened's adjusted earnings per share data for the three months ended in Mar. 2026 was zł1.041. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł1.37 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Biogened's average E10 Growth Rate was -0.70% per year. During the past 3 years, the average E10 Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biogened was 10.30% per year. The lowest was 8.80% per year. And the median was 9.55% per year.

As of today (2026-07-03), Biogened's current stock price is zł18.40. Biogened's E10 for the quarter that ended in Mar. 2026 was zł1.37. Biogened's Shiller PE Ratio of today is 13.43.

During the past 13 years, the highest Shiller PE Ratio of Biogened was 27.50. The lowest was 7.24. And the median was 14.69.


Biogened  (WAR:BGD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biogened's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=18.40/1.37
=13.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Biogened was 27.50. The lowest was 7.24. And the median was 14.69.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biogened E10 Related Terms


Biogened E10 Historical Data

* Premium members only.

The historical data trend for Biogened's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened E10 Chart

Biogened Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.97 1.01 1.12 1.30 1.30

Biogened Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.40 1.34 1.30 1.37

WAR:BGD vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biogened's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogened Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biogened's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biogened's Shiller PE Ratio falls into.


WAR:BGD
68GF Score
Biogened SA WAR:BGD
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogened E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biogened's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.041/163.0700*163.0700
=1.041

Current CPI (Mar. 2026) = 163.0700.

Biogened Quarterly Data

per share eps CPI Adj_EPS
201606 0.129 99.552 0.211
201609 0.144 99.064 0.237
201612 -0.032 100.366 -0.052
201703 0.195 101.018 0.315
201706 0.165 101.180 0.266
201709 0.060 101.343 0.097
201712 -0.012 102.564 -0.019
201803 0.201 102.564 0.320
201806 0.176 103.378 0.278
201809 0.040 103.378 0.063
201812 0.046 103.785 0.072
201903 0.255 104.274 0.399
201906 0.152 105.983 0.234
201909 0.027 105.983 0.042
201912 0.084 107.123 0.128
202003 0.321 109.076 0.480
202006 0.096 109.402 0.143
202009 0.129 109.320 0.192
202012 -0.041 109.565 -0.061
202103 0.375 112.658 0.543
202106 0.299 113.960 0.428
202109 0.024 115.588 0.034
202112 0.100 119.088 0.137
202203 0.704 125.031 0.918
202206 0.659 131.705 0.816
202209 0.125 135.531 0.150
202212 -0.112 139.113 -0.131
202303 0.765 145.950 0.855
202306 0.648 147.009 0.719
202309 0.241 146.113 0.269
202312 0.421 147.741 0.465
202403 0.856 149.044 0.937
202406 0.664 150.997 0.717
202409 0.043 153.439 0.046
202412 0.808 154.660 0.852
202503 0.942 157.021 0.978
202506 0.582 157.509 0.603
202509 0.003 158.000 0.003
202512 0.355 158.320 0.366
202603 1.041 163.070 1.041

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł1.37 mean?
Biogened (WAR:BGD) has a E10 of zł1.37 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biogened and its competitors.
Is Biogened's E10 too high?
Biogened's current E10 is zł1.37. Overall, Biogened has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biogened's E10 compare to ZTS and UTHR?
Biogened's E10 of zł1.37 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biogened and its competitors. Biogened's current E10 is zł1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogened stock overvalued right now?
Based on GuruFocus' analysis, Biogened (WAR:BGD) is currently considered Modestly Undervalued. The stock's GF Value™ is zł23.81, compared to a current price of zł18.40 — trading 22.7% below its estimated fair value. The current E10 is zł1.37. Biogened's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Biogened (WAR:BGD), the current E10 is zł1.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogened (WAR:BGD) Overvalued in 2026?

Based on GuruFocus' analysis, Biogened stock appears to be undervalued. The current stock price of zł18.40 is trading 22.7% below its estimated GF Value™ of zł23.81. GuruFocus considers Biogened to be Modestly Undervalued.

Key valuation signals for WAR:BGD:

  • E10: zł1.37
  • GF Value™: zł23.81 vs. price of zł18.40 (22.7% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the WAR:BGD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogened Business Description

Address Ulica Pojezierska 99, Lodz, POL, 91-342
Biogened SA is involved in manufacturing cosmetic and hygiene products. It also designs, produces, and markets safe, effective dermo-cosmetics under the Dermedic brand. The company's products include Dermocosmetics, Thermal water, and Pharmaceutical manufacturing conditions.
68GF Score

Get the complete analysis for WAR:BGD

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł18.40
Price
zł23.81
GF Value